Literature DB >> 7590888

Cytokine profile of circulating T cells of leprosy patients reflects both indiscriminate and polarized T-helper subsets: T-helper phenotype is stable and uninfluenced by related antigens of Mycobacterium leprae.

N Misra1, A Murtaza, B Walker, N P Narayan, R S Misra, V Ramesh, S Singh, M J Colston, I Nath.   

Abstract

Cytokine profiles of circulating mononuclear cells were studied with the aim of delineating T-cell subsets in leprosy patients with active disease. Using reverse transcriptase-polymerase chain reaction (RT-PCR) for cytokine mRNA and enzyme-linked immunoassay (ELISA) for the secreted products, interferon-gamma (IFN-gamma), interleukin-4 (IL-4), IL-6 and granulocyte-macrophage colony-stimulating factor (GM-CSF) were studied. Three antigens, native Mycobacterium leprae, a recombinant antigen LSR/A15 of M. leprae and peptide 624 spanning 58-77 amino acids of the latter, were used to induce cytokine expression and release. Half of the subjects, irrespective of the clinical type or antigen used, showed a mixed T-helper type 0 (Th0)-like cytokine pattern, with evidence of the concomitant presence of IFN-gamma and IL-4. The remainder showed a polarized pattern based on the type of leprosy. Lepromatous patients with disseminated disease had Th2-type cytokines, with IL-4 but not IFN-gamma. In contrast, tuberculoid leprosy patients with localized disease showed a Th1-like profile, with the presence of IFN-gamma but not IL-4. Of interest was the stability of the Th phenotype for M. leprae-related antigens. Both the recombinant and the peptide antigens induced the same phenotype as the natural M. leprae bacillus in all except four of 45 leprosy patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7590888      PMCID: PMC1383815     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  35 in total

1.  Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones.

Authors:  T F Gajewski; F W Fitch
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

2.  Profiles of lymphokine activities and helper function for IgE in human T cell clones.

Authors:  E Maggi; G Del Prete; D Macchia; P Parronchi; A Tiri; I Chrétien; M Ricci; S Romagnani
Journal:  Eur J Immunol       Date:  1988-07       Impact factor: 5.532

3.  Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction.

Authors:  K B Mullis; F A Faloona
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

5.  Accessory cell heterogeneity in lepromatous leprosy; dendritic cells and not monocytes support T cell responses.

Authors:  A Mittal; R S Mishra; I Nath
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

6.  Monocyte-derived soluble suppressor factor(s) in patients with lepromatous leprosy.

Authors:  M Sathish; L K Bhutani; A K Sharma; I Nath
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

7.  Cloned L3T4+ T lymphocytes protect mice against Listeria monocytogenes by secreting IFN-gamma.

Authors:  D M Magee; E J Wing
Journal:  J Immunol       Date:  1988-11-01       Impact factor: 5.422

8.  Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients.

Authors:  E A Wierenga; M Snoek; C de Groot; I Chrétien; J D Bos; H M Jansen; M L Kapsenberg
Journal:  J Immunol       Date:  1990-06-15       Impact factor: 5.422

9.  Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens.

Authors:  P Scott; P Natovitz; R L Coffman; E Pearce; A Sher
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

10.  Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.

Authors:  F P Heinzel; M D Sadick; B J Holaday; R L Coffman; R M Locksley
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

View more
  25 in total

1.  Lsr2 peptides of Mycobacterium leprae show hierarchical responses in lymphoproliferative assays, with selective recognition by patients with anergic lepromatous leprosy.

Authors:  Mehervani Chaduvula; A Murtaza; Namita Misra; N P Shankar Narayan; V Ramesh; H K Prasad; Rajni Rani; R K Chinnadurai; Indira Nath
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

2.  Evaluation of various cytokines elicited during antigen-specific recall as potential risk indicators for the differential development of leprosy.

Authors:  L H Sampaio; A L M Sousa; M C Barcelos; S G Reed; M M A Stefani; M S Duthie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-12       Impact factor: 3.267

3.  IL-10 promoter single nucleotide polymorphisms are significantly associated with resistance to leprosy.

Authors:  Dheeraj Malhotra; Katayoon Darvishi; Soni Sood; Swarkar Sharma; Chander Grover; Vineet Relhan; B S N Reddy; R N K Bamezai
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

4.  Changes in expression of signal transduction proteins in T lymphocytes of patients with leprosy.

Authors:  A H Zea; M T Ochoa; P Ghosh; D L Longo; W G Alvord; L Valderrama; R Falabella; L K Harvey; N Saravia; L H Moreno; A C Ochoa
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

5.  Induction of Th1 cytokine responses by mycobacterial antigens in leprosy.

Authors:  H M Dockrell; S K Young; K Britton; P J Brennan; B Rivoire; M F Waters; S B Lucas; F Shahid; M Dojki; T J Chiang; Q Ehsan; K P McAdam; R Hussain
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

6.  Murine experimental leprosy: Evaluation of immune response by analysis of peritoneal lavage cells and footpad histopathology.

Authors:  Fátima Regina Vilani-Moreno; Adriana Sierra Assêncio Almeida Barbosa; Beatriz Gomes Carreira Sartori; Suzana Madeira Diório; Sônia Maria Usó Ruiz Silva; Patrícia Sammarco Rosa; Andréa de Faria Fernandes Belone; Cleverson Teixeira Soares; José Roberto Pereira Lauris; Sílvia Cristina Barboza Pedrini
Journal:  Int J Exp Pathol       Date:  2019-05-24       Impact factor: 1.925

7.  Simultaneous analysis of multiple T helper subsets in leprosy reveals distinct patterns of Th1, Th2, Th17 and Tregs markers expression in clinical forms and reactional events.

Authors:  Michelle de Campos Soriani Azevedo; Heloisa Marques; Larissa Sarri Binelli; Mariana Silva Vieira Malange; Amanda Carreira Devides; Eliane Aparecida Silva; Luciana Raquel Vincenzi Fachin; Cassio Cesar Ghidella; Cleverson Teixeira Soares; Gustavo Pompermaier Garlet; Patrícia Sammarco Rosa; Andrea de Farias Fernandes Belone; Ana Paula Favaro Trombone
Journal:  Med Microbiol Immunol       Date:  2017-09-05       Impact factor: 3.402

8.  IgG subclass distribution of antibody responses to protein and polysaccharide mycobacterial antigens in leprosy and tuberculosis patients.

Authors:  A O Sousa; S Henry; F M Marója; F K Lee; L Brum; M Singh; P H Lagrange; P Aucouturier
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

9.  Interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) are necessary in the early stages of induction of CD4 and CD8 cytotoxic T cells by Mycobacterium leprae heat shock protein (hsp) 65 kD.

Authors:  M C Sasiain; S de la Barrera; S Fink; M Finiasz; M Alemán; M H Fariña; G Pizzariello; R Valdez
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

10.  Cytokine profiles of patients infected with Mycobacterium ulcerans and unaffected household contacts.

Authors:  Travis M Gooding; Paul D R Johnson; May Smith; Andrew S Kemp; Roy M Robins-Browne
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.